Well let's see, what kind of things has lousy engi
Post# of 72440
Quote:
Supposedly there's no partnership, isn't it possible that future dilution may happen in order to move forward and monetize those drugs in pipeline?
Then there is the claim that the share price is due only to Aspire selling (untrue) and making it sound as if Mr. Ehrlich had to beg an unwilling Aspire to buy shares in the first place (also untrue).
Quote:
Leo already tried to raise some money recently by selling shares to Aspire at a cheap price and that's most likely the primary cause for the share price to crater to new low.
And then we have just a flat-out "the sky is falling" statement. At least that makes it clear that his/her stance is negative on the company, and the unwary can look back at the previous paragraphs knowing that this is someone looking for things to boo-hoo about. We all know that "market conditions" do not matter when a biotech has good news. On the day of the great stock market crash of 1987, one biotech was up almost double on good news, as the market itself crashed horribly.
Quote:
I really hope something's coming out soon because the overall market condition doesn't look favorable now.
Read More: https://investorshangout.com/post/view?id=510...z5PTyrWEUG